Delivery Order SPE2DB24D2101-SPE2DB25FKMXK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract value of $1,780.51. This competitively awarded, firm fixed price delivery order is set to be completed by July 28, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under...
- The Defense Logistics Agency (DLA) awarded a $2,496.78 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price contract reflects a non-set-aside procurement and represents a routine pharmaceutical supply transaction under the company's existing federal contracting relationships. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,720.95 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract type. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,552.14 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packaging). This firm fixed-price, competitively awarded contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of BRILINTA 60 mg tablets. The firm-fixed-price contract, valued at $13,837.86, has an ultimate completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,418.96 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the procurement of 4,566,162,380 units of the medication BRILINTA 90 MG TABLET 60S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range...
- This is a $2,951.65 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. This delivery order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has an ultimate completion date of April 24, 2025 and a ceiling value of $2,687.32. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,922.04 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,905.13, is for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMXKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,044.86 and is classified as a non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Brilinta is an antiplatelet medication commonly used in cardiovascular treatment, and this delivery order represents a routine fulfillment under the company's expansive pharmaceutical prime vendor arrangement with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/30/25 |